Indication
Epilepsy
The Epilepsy pipeline: 72 tracked drugs, 43 approved for this indication.
43 approved / phase 412 Phase 32 Phase 2/36 Phase 26 Phase 1/23 Phase 1
Compare the share prices of listed companies in Epilepsy →
Total attributable cost
$40.8B
$12,000/patient
Drug spend
$18.4B
$5,417/patient
45% of total cost is drugs
All severities (active epilepsy) · US